Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
DURECT Corporation is a biopharmaceutical company focused on developing novel therapies for serious liver diseases and other unmet medical needs. Its core programs include the investigational epigenetic regulator larsucosterol for alcohol-associated hepatitis and metabolic liver conditions, as well as proprietary pain management products like POSIMIR. The company leverages strategic collaborations, patent protections, and a specialized manufacturing process to advance its innovative drug candidates.
This description was generated via AI from an annual report. Updated about 1 year ago.